HIROTAKA FUCHIZAWA, KIYOHIRO ANDO, NORIKO MOTOI, TOSHIHIKO IIZUKA, MASAHARU INOUE, KOUKI MITANI, YUTA SANO, HISANORI TAKENOBU, MASAYUKI HARUTA, RITSUKO ONUKI, et al. STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-γ-induced Apoptosis in Urothelial Cancer. Anticancer Research. 2024. 44. 5. 1925-1930
Kiyohiro Ando, Ryo Kurashina, Noriko Motoi, Toshihiko Iizuka, Masaharu Inoue, Riko Maruyama, Kouki Mitani, Hisanori Takenobu, Masayuki Haruta, Ritsuko Onuki, et al. Positive regulatory loop of platelet-derived growth factor DD-induced STAT3 activation is associated with poor prognosis in advanced urothelial carcinoma. Biochemical and Biophysical Research Communications. 2023. 676. 165-170
RYO KURASHINA, KIYOHIRO ANDO, MASAHARU INOUE, KEITA IZUMI, RIKO MARUYAMA, KOUKI MITANI, HISANORI TAKENOBU, MASAYUKI HARUTA, TOSHIHIKO IIZUKA, TAKEHIKO KAMIJO, et al. Platelet-to-Lymphocyte Ratio Predicts the Efficacy of Pembrolizumab in Patients With Urothelial Carcinoma. Anticancer Research. 2022. 42. 2. 1131-1136
Toshihiko Iizuka, Hiroko Nagano, Kimie Nomura, Miyako Hiramatsu, Noriko Motoi, Mingyon Mun, Yuichi Ishikawa. The combined use of long non-coding RNA HOTAIR and polycomb group protein EZH2 as a prognostic marker of lung adenocarcinoma. Cancer Treatment and Research Communications. 2022. 31. 100541-100541
Kumiko Umemoto, Yasushi Kojima, Naoyoshi Nagata, Chizu Yokoi, Toshiyuki Sakurai, Masao Kobayakawa, Toshihiko Iizuka, Toru Igari, Mikio Yanase, Junichi Akiyama. Cytomegalovirus esophagitis developing during chemoradiotherapy for esophageal cancer: two case reports. Journal of Medical Case Reports. 2016. 10. 1